| Year |
Citation |
Score |
| 2023 |
Hall M, Golubchik T, Bonsall D, Abeler-Dörner L, Limbada M, Kosloff B, Schaap A, de Cesare M, MacIntyre-Cockett G, Otecko N, Probert W, Ratmann O, Bulas Cruz A, Piwowar-Manning E, Burns DN, ... ... Eshleman SH, et al. Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study. The Lancet. Microbe. PMID 38081203 DOI: 10.1016/S2666-5247(23)00220-3 |
0.53 |
|
| 2023 |
Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, et al. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. The Lancet. Hiv. PMID 37952550 DOI: 10.1016/S2352-3018(23)00261-8 |
0.562 |
|
| 2023 |
Grant-McAuley W, Piwowar-Manning E, Clarke W, Breaud A, Zewdie KB, Moore A, Ayles HM, Kosloff B, Shanaube K, Bock P, Meehan SA, Maarman G, Fidler S, Hayes R, Donnell D, ... Eshleman SH, et al. Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART). Journal of the International Aids Society. 26: e26179. PMID 37886843 DOI: 10.1002/jia2.26179 |
0.591 |
|
| 2023 |
Marzinke MA, Hanscom B, Wang Z, Safren SA, Psaros C, Donnell D, Richardson PA, Sullivan P, Eshleman SH, Jennings A, Feliciano KG, Jalil E, Coutinho C, Cardozo N, Maia B, et al. Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial. The Lancet. Hiv. PMID 37783219 DOI: 10.1016/S2352-3018(23)00200-X |
0.537 |
|
| 2023 |
Grant-McAuley W, Morgenlander W, Hudelson SE, Thakar M, Piwowar-Manning E, Clarke W, Breaud A, Blankson J, Wilson E, Ayles H, Bock P, Moore A, Kosloff B, Shanaube K, Meehan SA, ... ... Eshleman SH, et al. Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load. Frontiers in Immunology. 14: 1178520. PMID 37744365 DOI: 10.3389/fimmu.2023.1178520 |
0.564 |
|
| 2023 |
Inzaule SC, Siedner MJ, Little SJ, Avila-Rios S, Ayitewala A, Bosch RJ, Calvez V, Ceccherini-Silberstein F, Charpentier C, Descamps D, Eshleman SH, Fokam J, Frenkel LM, Gupta RK, Ioannidis JPA, et al. Recommendations on data sharing in HIV drug resistance research. Plos Medicine. 20: e1004293. PMID 37738247 DOI: 10.1371/journal.pmed.1004293 |
0.649 |
|
| 2023 |
Bayan MH, Smalls T, Boudreau A, Mirza AW, Pasco C, Demko ZO, Rothman RE, Hsieh YH, Eshleman SH, Mostafa HH, Gonzalez-Jimenez N, Chavez PR, Emerson B, Delaney KP, Daugherty D, et al. Evaluating the impact of point-of-care HIV viral load assessment on linkage to care in Baltimore, MD: a randomized controlled trial. Bmc Infectious Diseases. 23: 570. PMID 37658305 DOI: 10.1186/s12879-023-08459-7 |
0.585 |
|
| 2023 |
Skalland T, Ayles H, Bock P, Bwalya J, Shanaube K, Kasese N, Dupré M, Kosloff B, Floyd S, Wilson E, Moore A, Eshleman S, Fidler S, Hayes R, Donnell D. Community- and individual-level correlates of HIV incidence in HPTN 071 (PopART). Journal of the International Aids Society. 26: e26155. PMID 37643290 DOI: 10.1002/jia2.26155 |
0.63 |
|
| 2023 |
Marzinke MA, Fogel JM, Wang Z, Piwowar-Manning E, Kofron R, Moser A, Bhandari P, Gollings R, Bushman LR, Weng L, Halvas EK, Mellors J, Anderson PL, Persaud D, Hendrix CW, ... ... Eshleman SH, et al. Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. Antimicrobial Agents and Chemotherapy. e0005323. PMID 36995219 DOI: 10.1128/aac.00053-23 |
0.841 |
|
| 2022 |
Remien RH, Dacus JD, Farley JE, Hughes JP, Gamble T, Wang ZZ, Batey DS, Mayer KH, Del Rio C, Balán IC, Irvin R, Mitchell KM, Cummings V, Eshleman SH, Conserve DF, et al. HTPN 078: an enhanced case management study to achieve viral suppression among viremic HIV-positive men who have sex with men in the United States. Aids (London, England). 37: 217-231. PMID 36541636 DOI: 10.1097/QAD.0000000000003411 |
0.46 |
|
| 2022 |
Fogel JM, Zewdie K, Clarke WA, Piwowar-Manning E, Breaud A, Moore A, Kosloff B, Shanaube K, van Zyl G, Scheepers M, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, ... ... Eshleman SH, et al. Antiretroviral Drug Detection in a Community-Randomized Trial of Universal HIV Testing and Treatment: HPTN 071 (PopART). Open Forum Infectious Diseases. 9: ofac576. PMID 36447611 DOI: 10.1093/ofid/ofac576 |
0.821 |
|
| 2022 |
Grant-McAuley W, Laeyendecker O, Monaco D, Chen A, Hudelson SE, Klock E, Brookmeyer R, Morrison D, Piwowar-Manning E, Morrison CS, Hayes R, Ayles H, Bock P, Kosloff B, Shanaube K, ... ... Eshleman SH, et al. Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment. Bmc Infectious Diseases. 22: 838. PMID 36368950 DOI: 10.1186/s12879-022-07850-0 |
0.513 |
|
| 2022 |
Palumbo PJ, Grant-McAuley W, Grabowski MK, Zhang Y, Richardson P, Piwowar-Manning E, Sharma D, Clarke W, Laeyendecker O, Rose S, Ha TV, Dumchev K, Djoerban Z, Redd A, Hanscom B, ... ... Eshleman SH, et al. Multiple infection and HIV superinfection among persons who inject drugs in Indonesia and Ukraine. The Journal of Infectious Diseases. PMID 36346452 DOI: 10.1093/infdis/jiac441 |
0.653 |
|
| 2022 |
Eshleman SH, Fogel JM, Halvas EK, Piwowar-Manning E, Marzinke MA, Kofron R, Wang Z, Mellors J, McCauley M, Rinehart AR, Clair MS, Adeyeye A, Hinojosa JC, Cabello R, Middelkoop K, et al. HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention. The Journal of Infectious Diseases. PMID 36240386 DOI: 10.1093/infdis/jiac415 |
0.848 |
|
| 2022 |
Fogel JM, Wilson EA, Piwowar-Manning E, Breaud A, Clarke W, Petropoulos C, Moore A, Fraser C, Kosloff B, Shanaube K, van Zyl G, Scheepers M, Floyd S, Bock P, Ayles H, ... ... Eshleman SH, et al. HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART). Journal of the International Aids Society. 25: e25941. PMID 35775502 DOI: 10.1002/jia2.25941 |
0.837 |
|
| 2022 |
Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, Kayange N, Makhema J, Mandima P, Mathew C, Spooner E, Mpendo J, Mukwekwerere P, Mgodi N, Ntege PN, ... ... Eshleman SH, et al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet (London, England). PMID 35378077 DOI: 10.1016/S0140-6736(22)00538-4 |
0.571 |
|
| 2022 |
Eshleman SH, Fogel JM, Piwowar-Manning E, Chau G, Cummings V, Agyei Y, Richardson P, Sullivan P, Haines CD, Bushman LR, Petropoulos C, Persaud D, Kofron R, Hendrix CW, Anderson PL, et al. Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084. The Journal of Infectious Diseases. PMID 35301540 DOI: 10.1093/infdis/jiab576 |
0.852 |
|
| 2021 |
Grant-McAuley W, Klock E, Laeyendecker O, Piwowar-Manning E, Wilson E, Clarke W, Breaud A, Moore A, Ayles H, Kosloff B, Shanaube K, Bock P, Mandla N, van Deventer A, Fidler S, ... ... Eshleman SH, et al. Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART). Plos One. 16: e0258644. PMID 34919554 DOI: 10.1371/journal.pone.0258644 |
0.424 |
|
| 2021 |
Klock E, Wilson E, Fernandez RE, Piwowar-Manning E, Moore A, Kosloff B, Bwalya J, Bell-Mandla N, James A, Ayles H, Bock P, Donnell D, Fidler S, Hayes R, Eshleman SH, et al. Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial. Journal of the International Aids Society. 24: e25830. PMID 34897992 DOI: 10.1002/jia2.25830 |
0.416 |
|
| 2021 |
Qiu X, Sokoll L, Duong Ly T, Coignard C, Eshleman SH, Mohr P, Huizenga C, Swanson P, Cloherty G, Hackett J. An improved HIV antigen/antibody prototype assay for earlier detection of acute HIV infection. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 145: 105022. PMID 34739837 DOI: 10.1016/j.jcv.2021.105022 |
0.597 |
|
| 2021 |
Kammers K, Chen A, Monaco DR, Hudelson SE, Grant-McAuley W, Moore RD, Alter G, Deeks SG, Morrison CS, Eller LA, Blankson JN, Laeyendecker O, Ruczinski I, Eshleman SH, Larman HB. HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression. Frontiers in Immunology. 12: 740395. PMID 34512672 DOI: 10.3389/fimmu.2021.740395 |
0.596 |
|
| 2021 |
Lancaster KE, Mollan KR, Hanscom BS, Shook-Sa BE, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Go VF, Dvoriak S, Reifeis SA, Piwowar-Manning EM, Richardson P, ... ... Eshleman SH, et al. Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074. Open Forum Infectious Diseases. 8: ofab281. PMID 34458390 DOI: 10.1093/ofid/ofab281 |
0.544 |
|
| 2021 |
Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, ... ... Eshleman SH, et al. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. The New England Journal of Medicine. 385: 595-608. PMID 34379922 DOI: 10.1056/NEJMoa2101016 |
0.647 |
|
| 2021 |
Soni N, Giguère K, Boily MC, Fogel JM, Maheu-Giroux M, Dimitrov D, Eshleman SH, Mitchell KM. Under-Reporting of Known HIV-Positive Status Among People Living with HIV: A Systematic Review and Meta-analysis. Aids and Behavior. PMID 34046763 DOI: 10.1007/s10461-021-03310-z |
0.787 |
|
| 2021 |
Marzinke MA, Grinsztejn B, Fogel JM, Piwowar-Manning E, Li M, Weng L, McCauley M, Cummings V, Ahmed S, Haines CD, Bushman LR, Petropoulos C, Persaud D, Adeyeye A, Kofron R, ... ... Eshleman SH, et al. Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083. The Journal of Infectious Diseases. PMID 33740057 DOI: 10.1093/infdis/jiab152 |
0.843 |
|
| 2021 |
Chen A, Laeyendecker O, Eshleman SH, Monaco DR, Kammers K, Larman HB, Ruczinski I. A top scoring pairs classifier for recent HIV infections. Statistics in Medicine. PMID 33660319 DOI: 10.1002/sim.8920 |
0.542 |
|
| 2021 |
Sandfort TGM, Mbilizi Y, Sanders EJ, Guo X, Cummings V, Hamilton EL, Akelo V, Panchia R, Dominguez K, Stirratt MJ, Chege W, Lucas J, Gaydos CA, Chen YQ, Eshleman SH. HIV incidence in a multinational cohort of men and transgender women who have sex with men in sub-Saharan Africa: Findings from HPTN 075. Plos One. 16: e0247195. PMID 33630925 DOI: 10.1371/journal.pone.0247195 |
0.65 |
|
| 2021 |
Palumbo PJ, Zhang Y, Clarke W, Breaud A, Sivay M, Cummings V, Hamilton EL, Guo X, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort TGM, Eshleman SH. Uptake of antiretroviral treatment and viral suppression among men who have sex with men and transgender women in sub-Saharan Africa in an observational cohort study: HPTN 075. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 33440260 DOI: 10.1016/j.ijid.2020.12.085 |
0.44 |
|
| 2021 |
Shafer RW, Dupnik K, Winters MA, Eshleman SH. A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies. Hiv Sequence Compendium. 2001: 1-51. PMID 22324021 |
0.561 |
|
| 2020 |
Grant-McAuley W, Fogel JM, Galai N, Clarke W, Breaud A, Marzinke MA, Mbwambo J, Likindikoki S, Aboud S, Donastorg Y, Perez M, Barrington C, Davis W, Kerrigan D, Eshleman SH. Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic. Plos One. 15: e0240890. PMID 33119663 DOI: 10.1371/journal.pone.0240890 |
0.849 |
|
| 2020 |
Sandfort TG, L Hamilton E, Marais A, Guo X, Sugarman J, Chen YQ, Cummings V, Dadabhai S, Dominguez K, Panchia R, Schnabel D, Zulu F, Reynolds D, Radebe O, Mbeda C, ... ... Eshleman SH, et al. The feasibility of recruiting and retaining men who have sex with men and transgender women in a multinational prospective HIV prevention research cohort study in sub-Saharan Africa (HPTN 075). Journal of the International Aids Society. 23: e25600. PMID 33000911 DOI: 10.1002/jia2.25600 |
0.601 |
|
| 2020 |
Fogel JM, Bonsall D, Cummings V, Bowden R, Golubchik T, de Cesare M, Wilson EA, Gamble T, Del Rio C, Batey DS, Mayer KH, Farley JE, Hughes JP, Remien RH, Beyrer C, ... ... Eshleman SH, et al. Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral load. The Journal of Antimicrobial Chemotherapy. PMID 32772080 DOI: 10.1093/Jac/Dkaa352 |
0.828 |
|
| 2020 |
Sivay MV, Palumbo PJ, Zhang Y, Cummings V, Guo X, Hamilton EL, McKinstry L, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort TGM, Eshleman SH. HIV drug resistance, phylogenetic analysis, and superinfection among men who have sex with men and transgender women in sub-Saharan Africa: HPTN 075. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32761071 DOI: 10.1093/Cid/Ciaa1136 |
0.705 |
|
| 2020 |
Sivay MV, Palumbo PJ, Zhang Y, Cummings V, Guo X, Hamilton EL, McKinstry L, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort TGM, Eshleman SH. HIV drug resistance, phylogenetic analysis, and superinfection among men who have sex with men and transgender women in sub-Saharan Africa: HPTN 075. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32750117 DOI: 10.1093/cid/ciaa1137 |
0.647 |
|
| 2020 |
Bonsall D, Golubchik T, de Cesare M, Limbada M, Kosloff B, MacIntyre-Cockett G, Hall M, Wymant C, Ansari MA, Abeler-Dörner L, Schaap A, Brown A, Barnes E, Piwowar-Manning E, Eshleman S, et al. A comprehensive genomics solution for HIV surveillance and clinical monitoring in low income settings. Journal of Clinical Microbiology. PMID 32669382 DOI: 10.1128/Jcm.00382-20 |
0.695 |
|
| 2020 |
Parkin NT, Avila-Rios S, Bibby DF, Brumme CJ, Eshleman SH, Harrigan PR, Howison M, Hunt G, Ji H, Kantor R, Ledwaba J, Lee ER, Matías-Florentino M, Mbisa JL, Noguera-Julian M, et al. Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping. Viruses. 12. PMID 32605062 DOI: 10.3390/V12070694 |
0.503 |
|
| 2020 |
Landovitz RJ, Li S, Eron JJ, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Eshleman SH, Kofron R, et al. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial. The Lancet. Hiv. PMID 32497491 DOI: 10.1016/S2352-3018(20)30106-5 |
0.53 |
|
| 2020 |
Blair CS, Li S, Chau G, Cottle L, Richardson P, Marzinke MA, Eshleman SH, Adeyeye A, Rinehart AR, Margolis D, McCauley M, Hendrix CW, Landovitz RJ. Hormonal Contraception Use and Cabotegravir Pharmacokinetics in HIV-Uninfected Women Enrolled in HPTN 077. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 32452972 DOI: 10.1097/Qai.0000000000002409 |
0.482 |
|
| 2020 |
Inzaule SC, Jordan MR, Bello G, Wadonda-Kabondo N, Mounerou S, Mbulli IA, Akanmu SA, Vubil A, Hunt G, Kaleebu P, Mthethwa-Hleza S, Dzangare J, Njukeng P, Penazzato M, de Wit TFR, ... Eshleman SH, et al. High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly-diagnosed antiretroviral treatment naive children in sub-Saharan Africa. Aids (London, England). PMID 32443062 DOI: 10.1097/Qad.0000000000002580 |
0.481 |
|
| 2020 |
Klock E, Mwinnyaa G, Eller LA, Fernandez R, Kibuuka H, Nitayaphan S, Kosgei J, Moore R, Robb M, Eshleman SH, Laeyendecker O. Impact of early ART initiation on performance of cross sectional incidence assays. Aids Research and Human Retroviruses. PMID 32295382 DOI: 10.1089/Aid.2019.0286 |
0.613 |
|
| 2020 |
Eshleman SH, Piwowar-Manning E, Wilson EA, Lennon D, Fogel JM, Agyei Y, Sullivan PA, Weng L, Moore A, Laeyendecker O, Kosloff B, Bwalya J, Maarman G, van Deventer A, Floyd S, et al. Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART). Journal of the International Aids Society. 23: e25452. PMID 32072743 DOI: 10.1002/Jia2.25452 |
0.857 |
|
| 2020 |
Zhang Y, Wymant C, Laeyendecker O, Grabowski MK, Hall M, Hudelson S, Piwowar-Manning E, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Mills LA, Santos BR, ... ... Eshleman SH, et al. Evaluation of phylogenetic methods for inferring the direction of HIV transmission: HPTN 052. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31922537 DOI: 10.1093/Cid/Ciz1247 |
0.689 |
|
| 2019 |
Sivay MV, Grabowski MK, Zhang Y, Palumbo PJ, Guo X, Piwowar-Manning E, Hamilton EL, Viet Ha T, Antonyak S, Imran D, Go V, Liulchuk M, Djauzi S, Hoffman I, Miller W, ... Eshleman SH, et al. Phylogenetic Analysis of Human Immunodeficiency Virus from People Who Inject Drugs in Indonesia, Ukraine, and Vietnam: HPTN 074. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31794031 DOI: 10.1093/Cid/Ciz1081 |
0.716 |
|
| 2019 |
Flys T, Nissley DV, Claasen CW, Jones D, Shi C, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH. Erratum to: Sensitive Drug-Resistance Assays Reveal Long-Term Persistence of HIV-1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single-Dose NVP: HIVNET 012. The Journal of Infectious Diseases. PMID 31776582 DOI: 10.1093/Infdis/Jiz524 |
0.854 |
|
| 2019 |
Fogel JM, Sivay MV, Cummings V, Wilson EA, Hart S, Gamble T, Laeyendecker O, Fernandez RE, Del Rio C, Batey DS, Mayer KH, Farley JE, McKinstry L, Hughes JP, Remien RH, ... ... Eshleman SH, et al. HIV drug resistance in a cohort of HIV-infected men who have sex with men in the United States. Aids (London, England). PMID 31634196 DOI: 10.1097/Qad.0000000000002394 |
0.858 |
|
| 2019 |
Palumbo PJ, Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Richardson P, Piwowar-Manning E, Hart S, Hamilton EL, Hoa NTK, Liulchuk M, Anandari L, Ha TV, Dumchev K, ... ... Eshleman SH, et al. HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074. Plos One. 14: e0223829. PMID 31600343 DOI: 10.1371/Journal.Pone.0223829 |
0.839 |
|
| 2019 |
Velloza J, Bacchetti P, Hendrix CW, Murnane P, Hughes JP, Li M, Curlin M, Holtz TH, Mannheimer S, Marzinke MA, Amico KR, Liu A, Piwowar-Manning E, Eshleman SH, Dye BJ, et al. Short and long-term pharmacologic measures of HIV pre-exposure prophylaxis use among high-risk men who have sex with men in HPTN 067/ADAPT. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31335588 DOI: 10.1097/Qai.0000000000002128 |
0.585 |
|
| 2019 |
Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, Yang B, Phiri M, Schaap A, Eshleman SH, Piwowar-Manning E, Kosloff B, James A, Skalland T, Wilson E, et al. Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART). The New England Journal of Medicine. 381: 207-218. PMID 31314965 DOI: 10.1056/Nejmoa1814556 |
0.637 |
|
| 2019 |
Sandfort TGM, Dominguez K, Kayange N, Ogendo A, Panchia R, Chen YQ, Chege W, Cummings V, Guo X, Hamilton EL, Stirratt M, Eshleman SH. HIV testing and the HIV care continuum among sub-Saharan African men who have sex with men and transgender women screened for participation in HPTN 075. Plos One. 14: e0217501. PMID 31150447 DOI: 10.1371/Journal.Pone.0217501 |
0.714 |
|
| 2019 |
Eshleman SH, Laeyendecker O, Kammers K, Chen A, Sivay MV, Kottapalli S, Sie BM, Yuan T, Monaco DR, Mohan D, Wansley D, Kula T, Morrison C, Elledge SJ, Brookmeyer R, et al. Comprehensive Profiling of HIV Antibody Evolution. Cell Reports. 27: 1422-1433.e4. PMID 31042470 DOI: 10.1016/J.Celrep.2019.03.097 |
0.56 |
|
| 2019 |
Stoner MCD, Dennis AM, Hughes JP, Eshleman SH, Sivay MV, Hudelson SE, Grabowski MK, Gómez-Olivé FX, MacPhail C, Piwowar-Manning E, Kahn K, Pettifor A. Characteristics Associated With Human Immunodeficiency Virus Transmission Networks Involving Adolescent Girls and Young Women in Human Immunodeficiency Virus Prevention Trials Network 068 Study. Sexually Transmitted Diseases. 46: e46-e49. PMID 30985638 DOI: 10.1097/Olq.0000000000000954 |
0.424 |
|
| 2019 |
Kobe JB, Talbot O, Chen I, Eshleman SH, Cummings V, Wheeler DP, Mayer KH, DeGruttola V. Viral genetic linkage analysis among Black men who have sex with men (HIV Prevention Trials Network 061). Aids Research and Human Retroviruses. PMID 30638029 DOI: 10.1089/Aid.2018.0204 |
0.758 |
|
| 2019 |
Fogel JM, Zhang Y, Palumbo PJ, Guo X, Clarke W, Breaud A, Richardson P, Piwowar-Manning E, Hamilton EL, Ha TV, Dumchev K, Djoerban Z, Hoffman I, Hanscom B, Miller WC, ... Eshleman SH, et al. Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs. Aids and Behavior. PMID 30600453 DOI: 10.1007/S10461-018-2379-8 |
0.841 |
|
| 2019 |
Rose R, Redd AD, Lamers S, Porcella SF, Hudelson SE, Piwowar-Manning E, McCauley M, Gamble T, Wilson EA, Kumwenda J, Hosseinipour MC, Hakim JG, Kumarasamy N, Chariyalertsak S, Pilotto JH, ... ... Eshleman SH, et al. A11 Evaluation of phylogenetic inference methods to determine direction of HIV transmission Virus Evolution. 5. DOI: 10.1093/Ve/Vez002.010 |
0.666 |
|
| 2018 |
Rose R, Hall M, Redd AD, Lamers S, Barbier AE, Porcella SF, Hudelson SE, Piwowar-Manning E, McCauley M, Gamble T, Wilson EA, Kumwenda J, Hosseinipour MC, Hakim JG, Kumarasamy N, ... ... Eshleman SH, et al. Phylogenetic methods inconsistently predict direction of HIV transmission among heterosexual pairs in the HPTN052 cohort. The Journal of Infectious Diseases. PMID 30590741 DOI: 10.1093/Infdis/Jiy734 |
0.622 |
|
| 2018 |
McGowan I, Wilkin T, Landovitz RJ, Wu C, Chen Y, Marzinke MA, Hendrix CW, Richardson P, Eshleman SH, Andrade A, Chege W, Anderson PL, McCauley M, Farley J, Mayer KH, et al. The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing PrEP Regimens in Men who have Sex with Men. Aids (London, England). PMID 30570571 DOI: 10.1097/QAD.0000000000002038 |
0.527 |
|
| 2018 |
McGowan I, Wilkin T, Landovitz RJ, Wu C, Chen Y, Marzinke MA, Hendrix CW, Richardson P, Eshleman SH, Andrade A, Chege W, Anderson PL, McCauley M, Farley J, Mayer KH, et al. The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing PrEP Regimens in Men who have Sex with Men. Aids (London, England). PMID 30557160 DOI: 10.1097/Qad.0000000000002038 |
0.604 |
|
| 2018 |
Sivay MV, Fogel JM, Wang J, Zhang Y, Piwowar-Manning E, Clarke W, Breaud A, Blankson J, Hamilton EL, Kahn K, Selin A, Gomez-Olive FX, MacPhail C, Hughes JP, Pettifor A, ... Eshleman SH, et al. Natural control of HIV infection in young women in South Africa: HPTN 068. Hiv Clinical Trials. 1-7. PMID 30522410 DOI: 10.1080/15284336.2018.1531534 |
0.85 |
|
| 2018 |
Stoner MCD, Dennis AM, Hughes JP, Eshleman SH, Sivay MV, Hudelson SE, Kate Grabowski M, Gomez-Olive X, MacPhail C, Piwowar-Manning E, Kahn K, Pettifor A. Characteristics associated with HIV transmission networks involving adolescent girls and young women in HIV Prevention Trials Network (HPTN) 068 study. Sexually Transmitted Diseases. PMID 30516725 DOI: 10.1097/OLQ.0000000000000954 |
0.485 |
|
| 2018 |
Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, et al. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. Plos Medicine. 15: e1002690. PMID 30408115 DOI: 10.1371/Journal.Pmed.1002690 |
0.617 |
|
| 2018 |
Lancaster KE, Hoffman IF, Hanscom B, Ha TV, Dumchev K, Susami H, Rose S, Go VF, Reifeis SA, Mollan KR, Hudgens MG, Piwowar-Manning EM, Richardson P, Dvoriak S, Djoerban Z, ... ... Eshleman SH, et al. Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis. Journal of the International Aids Society. 21: e25195. PMID 30350406 DOI: 10.1002/Jia2.25195 |
0.669 |
|
| 2018 |
Eisenberg AL, Patel EU, Packman Z, Fernandez R, Piwowar-Manning E, Hamilton EL, MacPhail C, Hughes JP, Pettifor A, Kallas E, Busch M, Murphy G, Quinn TC, Eshleman SH, Laeyendecker O. Dried blood spots stored at room temperature should not be used for HIV incidence testing. Aids Research and Human Retroviruses. PMID 30215267 DOI: 10.1089/Aid.2018.0138 |
0.519 |
|
| 2018 |
Miller WC, Hoffman IF, Hanscom BS, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Lancaster KE, Go VF, Dvoriak S, Mollan KR, Reifeis SA, Piwowar-Manning EM, ... ... Eshleman SH, et al. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study. Lancet (London, England). 392: 747-759. PMID 30191830 DOI: 10.1016/S0140-6736(18)31487-9 |
0.568 |
|
| 2018 |
Fogel JM, Sandfort T, Zhang Y, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Eshleman SH. Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study: HPTN 075. Aids and Behavior. PMID 30051192 DOI: 10.1007/S10461-018-2231-1 |
0.845 |
|
| 2018 |
Zhang Y, Sivay MV, Hudelson SE, Clarke W, Breaud A, Wang J, Piwowar-Manning E, Agyei Y, Fogel JM, Hamilton EL, Selin A, MacPhail C, Kahn K, Gomez-Olive FX, Hughes JP, ... ... Eshleman SH, et al. Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29985265 DOI: 10.1097/Qai.0000000000001793 |
0.84 |
|
| 2018 |
Sivay MV, Hudelson SE, Wang J, Agyei Y, Hamilton EL, Selin A, Dennis A, Kahn K, Gomez-Olive FX, MacPhail C, Hughes JP, Pettifor A, Eshleman SH, Grabowski MK. HIV-1 diversity among young women in rural South Africa: HPTN 068. Plos One. 13: e0198999. PMID 29975689 DOI: 10.1371/Journal.Pone.0198999 |
0.682 |
|
| 2018 |
Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort T, Eshleman SH. Antiretroviral drug use and HIV drug resistance among men who have sex with men and transgender women in sub-Saharan Africa: HPTN 075 study. Aids (London, England). PMID 29794492 DOI: 10.1097/Qad.0000000000001839 |
0.845 |
|
| 2018 |
Laeyendecker O, Konikoff J, Morrison DE, Brookmeyer R, Wang J, Celum C, Morrison CS, Abdool Karim Q, Pettifor AE, Eshleman SH. Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection. Journal of the International Aids Society. 21. PMID 29489059 DOI: 10.1002/Jia2.25082 |
0.496 |
|
| 2018 |
Grant RM, Mannheimer S, Hughes JP, Hirsch-Moverman Y, Loquere A, Chitwarakorn A, Curlin ME, Li M, Amico KR, Hendrix CW, Anderson PL, Dye BJ, Marzinke MA, Piwowar-Manning E, McKinstry L, ... ... Eshleman SH, et al. Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29420695 DOI: 10.1093/Cid/Cix1086 |
0.344 |
|
| 2018 |
Eshleman SH, Piwowar-Manning E, Sivay MV, Debevec B, Veater S, McKinstry L, Bekker LG, Mannheimer S, Grant RM, Chesney MA, Coates TJ, Koblin BA, Fogel JM. Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 99: 67-70. PMID 29346085 DOI: 10.1016/J.Jcv.2018.01.003 |
0.85 |
|
| 2017 |
Palumbo PJ, Fogel JM, Hudelson SE, Wilson EA, Hart S, Hovind L, Piwowar-Manning E, Wallis C, Papathanasopoulos MA, Morgado MG, Saravanan S, Tripathy S, Eron JJ, Gallant JE, Mph, ... ... Eshleman SH, et al. Hiv Drug Resistance in Adults Receiving Early Versus Delayed Antiretroviral Therapy: Hptn 052. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29293156 DOI: 10.1097/QAI.0000000000001623 |
0.766 |
|
| 2017 |
Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, ... ... Eshleman SH, et al. Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials. Statistical Communications in Infectious Diseases. 9. PMID 29218117 DOI: 10.1515/Scid-2016-0001 |
0.604 |
|
| 2017 |
Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, ... ... Eshleman SH, et al. Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials. Statistical Communications in Infectious Diseases. 9. PMID 29218117 DOI: 10.1515/Scid-2016-0001 |
0.604 |
|
| 2017 |
Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, ... ... Eshleman SH, et al. Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials. Statistical Communications in Infectious Diseases. 9. PMID 29218117 DOI: 10.1515/Scid-2016-0001 |
0.604 |
|
| 2017 |
Bekker LG, Roux S, Sebastien E, Yola N, Amico KR, Hughes JP, Marzinke MA, Hendrix CW, Anderson PL, Elharrar V, Stirratt M, Rooney JF, Piwowar-Manning E, Eshleman SH, McKinstry L, et al. Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. The Lancet. Hiv. PMID 28986029 DOI: 10.1016/S2352-3018(17)30156-X |
0.445 |
|
| 2017 |
Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, et al. Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial. Annals of Internal Medicine. 1-10. PMID 28828489 DOI: 10.7326/M17-0520 |
0.69 |
|
| 2017 |
Greer AE, Ou SS, Wilson E, Piwowar-Manning E, Forman MS, McCauley M, Gamble T, Ruangyuttikarn C, Hosseinipour MC, Kumarasamy N, Nyirenda M, Grinsztejn B, Pilotto JH, Kosashunhanan N, Gonçalves de Melo M, ... ... Eshleman SH, et al. A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28749822 DOI: 10.1097/Qai.0000000000001511 |
0.667 |
|
| 2017 |
Palumbo PJ, Wilson EA, Piwowar-Manning E, McCauley M, Gamble T, Kumwenda N, Makhema J, Kumarasamy N, Chariyalertsak S, Hakim JG, Hosseinipour MC, Melo MG, Godbole SV, Pilotto JH, Grinsztejn B, ... ... Eshleman SH, et al. Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052. Plos One. 12: e0177281. PMID 28481902 DOI: 10.1371/Journal.Pone.0177281 |
0.851 |
|
| 2017 |
Fogel JM, Piwowar-Manning E, Debevec B, Walsky T, Schlusser K, Laeyendecker O, Wilson EA, McCauley M, Gamble T, Tegha G, Biomed M, Soko D, Kumwenda J, Hosseinipour MC, Chen YQ, ... ... Eshleman SH, et al. Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28471839 DOI: 10.1097/Qai.0000000000001421 |
0.849 |
|
| 2017 |
Zhang Y, Clarke W, Marzinke MA, Piwowar-Manning E, Beauchamp G, Breaud A, Hendrix CW, Cloherty GA, Emel L, Rose S, Hightow-Weidman L, Siegel M, Shoptaw S, Fields SD, Wheeler D, ... Eshleman SH, et al. Evaluation of a multi-drug assay for monitoring adherence to a regimen for HIV pre-exposure prophylaxis in a clinical study (HIV Prevention Trials Network 073). Antimicrobial Agents and Chemotherapy. PMID 28438932 DOI: 10.1128/Aac.02743-16 |
0.623 |
|
| 2017 |
Eshleman SH, Wilson EA, Zhang XC, Ou SS, Piwowar-Manning E, Eron JJ, McCauley M, Gamble T, Gallant JE, Hosseinipour MC, Kumarasamy N, Hakim JG, Kalonga B, Pilotto JH, Grinsztejn B, et al. Virologic outcomes in early antiretroviral treatment: HPTN 052. Hiv Clinical Trials. 1-10. PMID 28385131 DOI: 10.1080/15284336.2017.1311056 |
0.825 |
|
| 2017 |
Chen I, Zhang Y, Cummings V, Cloherty GA, Connor M, Beauchamp G, Griffith S, Rose S, Gallant J, Scott HM, Shoptaw S, Del Rio C, Kuo I, Mannheimer S, Tieu HV, ... ... Eshleman SH, et al. Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States. Aids Research and Human Retroviruses. PMID 28384058 DOI: 10.1089/Aid.2017.0005 |
0.777 |
|
| 2017 |
Sivay MV, Li M, Piwowar-Manning E, Zhang Y, Hudelson SE, Marzinke MA, Amico RK, Redd A, Hendrix CW, Anderson PL, Bokoch K, Gail-Bekker L, van Griensven F, Mannheimer S, Hughes JP, ... ... Eshleman SH, et al. Characterization of HIV seroconverters in a TDF/FTC PrEP study: HPTN 067/ADAPT. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28328548 DOI: 10.1097/Qai.0000000000001374 |
0.62 |
|
| 2017 |
Schlusser KE, Konikoff J, Kirkpatrick AR, Morrison C, Chipato T, Chen PL, Munjoma M, Eshleman SH, Laeyendecker O. Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence. Aids Research and Human Retroviruses. PMID 28318310 DOI: 10.1089/Aid.2016.0245 |
0.56 |
|
| 2017 |
Schlusser KE, Pilcher C, Kallas EG, Santos BR, Deeks SG, Facente S, Keating SM, Busch MP, Murphy G, Welte A, Quinn T, Eshleman SH, Laeyendecker O. Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma. Plos One. 12: e0172283. PMID 28231277 DOI: 10.1371/Journal.Pone.0172283 |
0.536 |
|
| 2016 |
Chen I, Chau G, Wang J, Clarke W, Marzinke MA, Cummings V, Breaud A, Laeyendecker O, Fields SD, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, ... ... Eshleman SH, et al. Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061). Plos One. 11: e0167629. PMID 27936098 DOI: 10.1371/Journal.Pone.0167629 |
0.786 |
|
| 2016 |
Wendel SK, Longosz AF, Eshleman SH, Blankson J, Moore R, Kerully J, Quinn TC, Laeyendecker O. The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection. Aids Research and Human Retroviruses. PMID 27875908 DOI: 10.1089/Aid.2016.0105 |
0.475 |
|
| 2016 |
Fogel JM, Clarke W, Kulich M, Piwowar-Manning E, Breaud A, Olson MT, Marzinke MA, Laeyendecker O, Fiamma A, Donnell D, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, ... Eshleman SH, et al. Antiretroviral drug use in a cross-sectional population survey in Africa: NIMH Project Accept (HPTN 043). Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27828875 DOI: 10.1097/Qai.0000000000001229 |
0.803 |
|
| 2016 |
Pettifor A, MacPhail C, Hughes JP, Selin A, Wang J, Gómez-Olivé FX, Eshleman SH, Wagner RG, Mabuza W, Khoza N, Suchindran C, Mokoena I, Twine R, Andrew P, Townley E, et al. The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial. The Lancet. Global Health. PMID 27815148 DOI: 10.1016/S2214-109X(16)30253-4 |
0.652 |
|
| 2016 |
Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, et al. PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305). The Journal of Infectious Diseases. PMID 27811319 DOI: 10.1093/Infdis/Jiw525 |
0.641 |
|
| 2016 |
Cohen M, Eshleman S, McCauley M, Chen Y. Antiretroviral therapy to prevent HIV acquisition: Limits of estimation from a population cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27694481 DOI: 10.1093/Cid/Ciw673 |
0.589 |
|
| 2016 |
Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou SS, Zhang XC, Ping LH, Piwowar-Manning E, Porcella SF, Sievers MF, Martens CA, Bruno D, Dukhovlinova E, McCauley M, Gamble T, et al. Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27532476 DOI: 10.1097/Qai.0000000000001158 |
0.818 |
|
| 2016 |
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, ... Eshleman SH, et al. Antiretroviral Therapy for the Prevention of HIV-1 Transmission. The New England Journal of Medicine. PMID 27424812 DOI: 10.1056/Nejmoa1600693 |
0.646 |
|
| 2016 |
Chen I, Huang W, Connor MB, Frantzell A, Cummings V, Beauchamp GG, Griffith S, Fields SD, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, ... ... Eshleman SH, et al. CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061. Hiv Clinical Trials. 1-7. PMID 27300696 DOI: 10.1080/15284336.2016.1180771 |
0.759 |
|
| 2016 |
Agwu AL, Yao TJ, Eshleman SH, Patel K, Huang W, Burchett SK, Siberry GK, Van Dyke RB. Phenotypic Co-receptor Tropism in Perinatally HIV-Infected Youth Failing Antiretroviral Therapy. The Pediatric Infectious Disease Journal. PMID 27078121 DOI: 10.1097/Inf.0000000000001158 |
0.53 |
|
| 2016 |
Kirkpatrick AR, Patel EU, Celum C, Moore R, Blankson J, Mehta S, Kirk G, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O. Development and Evaluation of a Modified Fourth Generation HIV Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. Aids Research and Human Retroviruses. PMID 26988426 DOI: 10.1089/Aid.2015.0198 |
0.582 |
|
| 2016 |
Fogel JM, Hudelson SE, Ou SS, Hart S, Wallis C, Morgado MG, Saravanan S, Tripathy S, Hovind L, Piwowar-Manning E, Sabin D, McCauley M, Gamble T, Zhang XC, Eron JJ, ... ... Eshleman SH, et al. HIV drug resistance in adults failing early antiretroviral treatment: results from the HIV Prevention Trials Network 052 trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26859828 DOI: 10.1097/Qai.0000000000000951 |
0.836 |
|
| 2015 |
Chen I, Clarke W, Ou SS, Marzinke MA, Breaud A, Emel LM, Wang J, Hughes JP, Richardson P, Haley DF, Lucas J, Rompalo A, Justman JE, Hodder SL, Eshleman SH. Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064. Plos One. 10: e0140074. PMID 26445283 DOI: 10.1371/Journal.Pone.0140074 |
0.723 |
|
| 2015 |
Redd AD, Wendel SK, Longosz AF, Fogel JM, Dadabhai S, Kumwenda N, Sun J, Walker MP, Bruno D, Martens C, Eshleman SH, Porcella SF, Quinn TC, Taha TE. Evaluation of postpartum HIV superinfection and mother-to-child transmission. Aids (London, England). 29: 1567-73. PMID 26244396 DOI: 10.1097/Qad.0000000000000740 |
0.854 |
|
| 2015 |
Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, ... ... Eshleman SH, et al. Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis. Plos Medicine. 12: e1001845. PMID 26030872 DOI: 10.1371/journal.pmed.1001845 |
0.468 |
|
| 2015 |
Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, ... ... Eshleman SH, et al. Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 446-52. PMID 25861015 DOI: 10.1097/Qai.0000000000000633 |
0.86 |
|
| 2015 |
Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, ... ... Eshleman SH, et al. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis. Plos Medicine. 12: e1001810. PMID 25849352 DOI: 10.1371/Journal.Pmed.1001810 |
0.682 |
|
| 2015 |
Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, ... Eshleman SH, et al. Determination of HIV Status in African Adults With Discordant HIV Rapid Tests. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 430-8. PMID 25835607 DOI: 10.1097/Qai.0000000000000610 |
0.847 |
|
| 2015 |
Laeyendecker O, Redd AD, Nason M, Longosz AF, Karim QA, Naranbhai V, Garrett N, Eshleman SH, Abdool Karim SS, Quinn TC. Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. The Journal of Infectious Diseases. PMID 25712973 DOI: 10.1093/Infdis/Jiv110 |
0.583 |
|
| 2015 |
Kantor R, Smeaton L, Vardhanabhuti S, Hudelson SE, Wallis CL, Tripathy S, Morgado MG, Saravanan S, Balakrishnan P, Reitsma M, Hart S, Mellors JW, Halvas E, Grinsztejn B, Hosseinipour MC, ... ... Eshleman SH, et al. Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1541-9. PMID 25681380 DOI: 10.1093/Cid/Civ102 |
0.631 |
|
| 2015 |
Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 62: 75-9. PMID 25542477 DOI: 10.1016/J.Jcv.2014.11.023 |
0.856 |
|
| 2015 |
Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O. Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. Aids Research and Human Retroviruses. 31: 421-7. PMID 25317854 DOI: 10.1089/Aid.2014.0081 |
0.636 |
|
| 2014 |
Lindsey JC, Hughes MD, Violari A, Eshleman SH, Abrams EJ, Bwakura-Dangarembizi M, Barlow-Mosha L, Kamthunzi P, Sambo PM, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Zimmer B, et al. Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission. The Pediatric Infectious Disease Journal. 33: 846-54. PMID 25222305 DOI: 10.1097/Inf.0000000000000337 |
0.608 |
|
| 2014 |
Mannheimer SB, Wang L, Wilton L, Van Tieu H, Del Rio C, Buchbinder S, Fields S, Glick S, Connor MB, Cummings V, Eshleman SH, Koblin B, Mayer KH. Infrequent HIV testing and late HIV diagnosis are common among a cohort of black men who have sex with men in 6 US cities. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 438-45. PMID 25197830 DOI: 10.1097/Qai.0000000000000334 |
0.651 |
|
| 2014 |
Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, ... Eshleman SH, et al. Low-level Viremia early in HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 405-8. PMID 25140905 DOI: 10.1097/Qai.0000000000000298 |
0.888 |
|
| 2014 |
Coates TJ, Kulich M, Celentano DD, Zelaya CE, Chariyalertsak S, Chingono A, Gray G, Mbwambo JK, Morin SF, Richter L, Sweat M, van Rooyen H, McGrath N, Fiamma A, Laeyendecker O, ... ... Eshleman SH, et al. Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. The Lancet. Global Health. 2: e267-77. PMID 25103167 DOI: 10.1016/S2214-109X(14)70032-4 |
0.611 |
|
| 2014 |
Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, ... ... Eshleman SH, et al. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. Plos One. 9: e101043. PMID 24968135 DOI: 10.1371/Journal.Pone.0101043 |
0.696 |
|
| 2014 |
Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke MA, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Mannheimer S, Del Rio C, Kuo I, ... ... Eshleman SH, et al. Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. Hiv Clinical Trials. 15: 62-8. PMID 24710920 DOI: 10.1310/Hct1502-62 |
0.86 |
|
| 2014 |
Marzinke MA, Breaud A, Parsons TL, Cohen MS, Piwowar-Manning E, Eshleman SH, Clarke W. The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood. Clinica Chimica Acta; International Journal of Clinical Chemistry. 433: 157-68. PMID 24661980 DOI: 10.1016/J.Cca.2014.03.016 |
0.602 |
|
| 2014 |
Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, ... ... Eshleman SH, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. The Lancet. Infectious Diseases. 14: 281-90. PMID 24602844 DOI: 10.1016/S1473-3099(13)70692-3 |
0.661 |
|
| 2014 |
Longosz AF, Morrison CS, Chen PL, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O. Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 390-6. PMID 24583613 DOI: 10.1097/Qai.0000000000000006 |
0.487 |
|
| 2014 |
Longosz AF, Mehta SH, Kirk GD, Margolick JB, Brown J, Quinn TC, Eshleman SH, Laeyendecker O. Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. Aids (London, England). 28: 1227-32. PMID 24513567 DOI: 10.1097/Qad.0000000000000221 |
0.62 |
|
| 2014 |
Mayer KH, Wang L, Koblin B, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson CC, Piwowar-Manning E, Gaydos C, Eshleman SH, Clarke W, Liu TY, et al. Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities. Plos One. 9: e87298. PMID 24498067 DOI: 10.1371/Journal.Pone.0087298 |
0.559 |
|
| 2014 |
Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, ... ... Eshleman SH, et al. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 366-74. PMID 24189151 DOI: 10.1097/Qai.0000000000000052 |
0.582 |
|
| 2014 |
Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, ... ... Eshleman SH, et al. HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm. Journal of Clinical Microbiology. 52: 115-21. PMID 24153134 DOI: 10.1128/Jcm.02040-13 |
0.595 |
|
| 2014 |
Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, ... ... Eshleman SH, et al. Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 117-20. PMID 24092804 DOI: 10.1093/Cid/Cit672 |
0.869 |
|
| 2014 |
Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda. Aids Research and Human Retroviruses. 30: 339-44. PMID 24083837 DOI: 10.1089/Aid.2013.0169 |
0.422 |
|
| 2014 |
Mirochnick M, Taha T, Kreitchmann R, Nielsen-Saines K, Kumwenda N, Joao E, Pinto J, Santos B, Parsons T, Kearney B, Emel L, Herron C, Richardson P, Hudelson SE, Eshleman SH, et al. Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 33-41. PMID 23979002 DOI: 10.1097/Qai.0B013E3182A921Eb |
0.537 |
|
| 2014 |
Ng OT, Laeyendecker O, Redd AD, Munshaw S, Grabowski MK, Paquet AC, Evans MC, Haddad M, Huang W, Robb ML, Reynolds SJ, Gray RH, Wawer MJ, Serwadda D, Eshleman SH, et al. HIV type 1 polymerase gene polymorphisms are associated with phenotypic differences in replication capacity and disease progression. The Journal of Infectious Diseases. 209: 66-73. PMID 23922373 DOI: 10.1093/Infdis/Jit425 |
0.608 |
|
| 2013 |
Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, ... ... Eshleman SH, et al. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. Plos One. 8: e82772. PMID 24386116 DOI: 10.1371/Journal.Pone.0082772 |
0.524 |
|
| 2013 |
Chen I, Khaki L, Lindsey JC, Fry C, Cousins MM, Siliciano RF, Violari A, Palumbo P, Eshleman SH. Association of pol diversity with antiretroviral treatment outcomes among HIV-infected African children. Plos One. 8: e81213. PMID 24312277 DOI: 10.1371/Journal.Pone.0081213 |
0.713 |
|
| 2013 |
Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison CS, Salata RA, Chipato T, Celum C, ... ... Eshleman SH, et al. Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. Plos One. 8: e78818. PMID 24236054 DOI: 10.1371/Journal.Pone.0078818 |
0.609 |
|
| 2013 |
Ping LH, Jabara CB, Rodrigo AG, Hudelson SE, Piwowar-Manning E, Wang L, Eshleman SH, Cohen MS, Swanstrom R. HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study. Plos One. 8: e71557. PMID 24086252 DOI: 10.1371/Journal.Pone.0071557 |
0.663 |
|
| 2013 |
Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L, Liu TY, Cummings V, Piwowar-Manning E, Fields SD, Griffith S, et al. Correlates of HIV acquisition in a cohort of Black men who have sex with men in the United States: HIV prevention trials network (HPTN) 061. Plos One. 8: e70413. PMID 23922989 DOI: 10.1371/Journal.Pone.0070413 |
0.648 |
|
| 2013 |
Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Sanne I, Kumarasamy N, Grinsztejn B, ... ... Eshleman SH, et al. Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). The Journal of Infectious Diseases. 208: 1624-8. PMID 23908493 DOI: 10.1093/Infdis/Jit390 |
0.773 |
|
| 2013 |
Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Swanson P, Hackett J, Clarke W, Marzinke M, Szekeres G, Gray G, Richter L, ... ... Eshleman SH, et al. Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). Plos One. 8: e68349. PMID 23874597 DOI: 10.1371/Journal.Pone.0068349 |
0.699 |
|
| 2013 |
Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH. Cross-sectional HIV incidence estimation in HIV prevention research. Journal of Acquired Immune Deficiency Syndromes (1999). 63: S233-9. PMID 23764641 DOI: 10.1097/Qai.0B013E3182986Fdf |
0.592 |
|
| 2013 |
Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, ... ... Eshleman SH, et al. Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. The Journal of Infectious Diseases. 207: S70-7. PMID 23687292 DOI: 10.1093/Infdis/Jit114 |
0.333 |
|
| 2013 |
Mullis CE, Munshaw S, Grabowski MK, Eshleman SH, Serwadda D, Brookmeyer R, Nalugoda F, Kigozi G, Kagaayi J, Tobian AA, Wawer M, Gray RH, Quinn TC, Laeyendecker O. Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda. Aids Research and Human Retroviruses. 29: 1146-50. PMID 23641870 DOI: 10.1089/Aid.2012.0105 |
0.559 |
|
| 2013 |
James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH. Antibody maturation and viral diversification in HIV-infected women. Plos One. 8: e57350. PMID 23460842 DOI: 10.1371/Journal.Pone.0057350 |
0.801 |
|
| 2013 |
Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Brookmeyer R, Quinn TC, Laeyendecker O. Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection. Plos One. 8: e55525. PMID 23437058 DOI: 10.1371/Journal.Pone.0055525 |
0.634 |
|
| 2013 |
Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH. Estimation of HIV incidence using multiple biomarkers. American Journal of Epidemiology. 177: 264-72. PMID 23302151 DOI: 10.1093/Aje/Kws436 |
0.651 |
|
| 2013 |
Hodder SL, Justman J, Hughes JP, Wang J, Haley DF, Adimora AA, Del Rio C, Golin CE, Kuo I, Rompalo A, Soto-Torres L, Mannheimer SB, Johnson-Lewis L, Eshleman SH, El-Sadr WM, et al. HIV acquisition among women from selected areas of the United States: a cohort study. Annals of Internal Medicine. 158: 10-8. PMID 23277896 DOI: 10.7326/0003-4819-158-1-201301010-00004 |
0.645 |
|
| 2013 |
Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K, Mofenson LM, Zwerski S, Coovadia HM, Eshleman SH. Impact of maternal and infant antiretroviral drug regimens on drug resistance in HIV-infected breastfeeding infants. The Pediatric Infectious Disease Journal. 32: e164-9. PMID 23249916 DOI: 10.1097/Inf.0B013E31827F44Ee |
0.826 |
|
| 2013 |
Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, ... ... Eshleman SH, et al. HIV incidence determination in the United States: a multiassay approach. The Journal of Infectious Diseases. 207: 232-9. PMID 23129760 DOI: 10.1093/Infdis/Jis659 |
0.673 |
|
| 2013 |
Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, Johnson-Lewis L, Mullis CE, Hackett J, Vallari AS, Justman J, Hodder S. Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. The Journal of Infectious Diseases. 207: 223-31. PMID 23129758 DOI: 10.1093/Infdis/Jis658 |
0.707 |
|
| 2013 |
Chen I, Khaki L, Lindsey JC, Fry C, Cousins MM, Siliciano RF, Violari A, Palumbo P, Eshleman SH. Correction: Association of pol Diversity with Antiretroviral Treatment Outcomes among HIV-Infected African Children Plos One. 8. DOI: 10.1371/annotation/dd945f7c-c50b-461d-ab38-15e8b0966458 |
0.505 |
|
| 2013 |
Chen I, Khaki L, Lindsey JC, Fry C, Cousins MM, Siliciano RF, Violari A, Palumbo P, Eshleman SH. Correction: Association of pol Diversity with Antiretroviral Atment Outcomes among HIV-Infected African Children Plos One. 8. DOI: 10.1371/annotation/6937ccda-2f54-430d-94d0-b71d1ecc5273 |
0.515 |
|
| 2012 |
Cousins MM, Swan D, Magaret CA, Hoover DR, Eshleman SH. Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence. Plos One. 7: e51359. PMID 23240016 DOI: 10.1371/Journal.Pone.0051359 |
0.679 |
|
| 2012 |
Cousins MM, Ou SS, Wawer MJ, Munshaw S, Swan D, Magaret CA, Mullis CE, Serwadda D, Porcella SF, Gray RH, Quinn TC, Donnell D, Eshleman SH, Redd AD. Comparison of a high-resolution melting assay to next-generation sequencing for analysis of HIV diversity. Journal of Clinical Microbiology. 50: 3054-9. PMID 22785188 DOI: 10.1128/Jcm.01460-12 |
0.537 |
|
| 2012 |
James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel JM, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH. Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. The Pediatric Infectious Disease Journal. 31: e222-8. PMID 22785048 DOI: 10.1097/Inf.0B013E3182678C3F |
0.868 |
|
| 2012 |
Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P, Chi BH, Cotton MF, Moultrie H, Khadse S, Schimana W, Bobat R, Purdue L, Eshleman SH, Abrams EJ, et al. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. The New England Journal of Medicine. 366: 2380-9. PMID 22716976 DOI: 10.1056/Nejmoa1113249 |
0.571 |
|
| 2012 |
Fogel JM, Taha TE, Sun J, Hoover DR, Parsons TL, Kumwenda JJ, Mofenson LM, Fowler MG, Hendrix CW, Kumwenda NI, Eshleman SH, Mirochnick M. Stavudine concentrations in women receiving postpartum antiretroviral treatment and their breastfeeding infants. Journal of Acquired Immune Deficiency Syndromes (1999). 60: 462-5. PMID 22614899 DOI: 10.1097/Qai.0B013E31825Ddcfa |
0.669 |
|
| 2012 |
Reynolds SJ, Laeyendecker O, Nakigozi G, Gallant JE, Huang W, Hudelson SE, Quinn TC, Newell K, Serwadda D, Gray RH, Wawer MJ, Eshleman SH. Antiretroviral drug susceptibility among HIV-infected adults failing antiretroviral therapy in Rakai, Uganda. Aids Research and Human Retroviruses. 28: 1739-44. PMID 22443282 DOI: 10.1089/Aid.2011.0352 |
0.468 |
|
| 2012 |
Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. Aids Research and Human Retroviruses. 28: 1177-83. PMID 22283149 DOI: 10.1089/Aid.2011.0341 |
0.557 |
|
| 2012 |
Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W, Nakabiito C, Msweli L, Kisenge R, Guay L, Mwatha A, ... ... Eshleman SH, et al. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial. Lancet. 379: 221-8. PMID 22196945 DOI: 10.1016/S0140-6736(11)61653-X |
0.606 |
|
| 2012 |
Beck IA, Jang M, McKernan-Mullin J, Bull M, Wagner T, Huang S, Song LY, Nachman S, Krogstad P, Eshleman SH, Wiznia A, Frenkel LM. Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure. Aids Research and Human Retroviruses. 28: 780-8. PMID 22081867 DOI: 10.1089/Aid.2011.0039 |
0.598 |
|
| 2012 |
Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH. Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. Aids Research and Human Retroviruses. 28: 816-22. PMID 22014036 DOI: 10.1089/Aid.2011.0258 |
0.701 |
|
| 2012 |
Redd AD, Laeyendecker O, Kong X, Kiwanuka N, Lutalo T, Huang W, Gray RH, Wawer MJ, Serwadda D, Eshleman SH, Quinn TC. Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression. Aids Research and Human Retroviruses. 28: 289-94. PMID 21663455 DOI: 10.1089/Aid.2011.0006 |
0.662 |
|
| 2012 |
Conradie F, Zheng Y, Hosseinipour M, Mellors J, Sawe F, Eshleman S, Mohapi L, Chipato T, Asmelash A, Stringer E, Siika A, Rwambuya S, Ramnarain P, Hogg E, Blanchard-Horan C, et al. Approaches to effectively documenting prior single dose nevirapine exposure among women in Africa Annals of Tropical Medicine and Public Health. 5: 344-348. DOI: 10.4103/1755-6783.102051 |
0.443 |
|
| 2011 |
Sista ND, Abdool Karim Q, Hinson K, Donnell D, Eshleman SH, Vermund SH. Experience in international clinical research: the HIV Prevention Trials Network. Clinical Investigation. 1: 1609-1618. PMID 22348195 DOI: 10.4155/Cli.11.156 |
0.698 |
|
| 2011 |
Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, Khaki L, Koblin B, Chesney M, Moore RD, Kelen GD, Coates T, Celum C, Buchbinder SP, Seage GR, ... ... Eshleman SH, et al. Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. Plos One. 6: e27211. PMID 22073290 DOI: 10.1371/Journal.Pone.0027211 |
0.711 |
|
| 2011 |
Laeyendecker O, Latimore A, Eshleman SH, Summerton J, Oliver AE, Gamiel J, Dobbs T, Mei J, Murphy G, Parry JV, Owen SM, Quinn TC. The effect of sample handling on cross sectional HIV incidence testing results. Plos One. 6: e25899. PMID 22046249 DOI: 10.1371/Journal.Pone.0025899 |
0.476 |
|
| 2011 |
Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF, Munshaw S, Ray SC, Piwowar-Manning E, McCauley M, Hosseinipour MC, et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. The Journal of Infectious Diseases. 204: 1918-26. PMID 21990420 DOI: 10.1093/Infdis/Jir651 |
0.702 |
|
| 2011 |
Ziemniak C, Mengistu Y, Ruff A, Chen YH, Khaki L, Bedri A, Simen BB, Palumbo P, Eshleman SH, Persaud D. Use of dried-blood-spot samples and in-house assays to identify antiretroviral drug resistance in HIV-infected children in resource-constrained settings. Journal of Clinical Microbiology. 49: 4077-82. PMID 21956987 DOI: 10.1128/Jcm.01004-11 |
0.689 |
|
| 2011 |
Piwowar-Manning E, Fiamma A, Laeyendecker O, Kulich M, Donnell D, Szekeres G, Robins-Morris L, Mullis CE, Vallari A, Hackett J, Mastro TD, Gray G, Richter L, Alexandre MW, Chariyalertsak S, ... ... Eshleman SH, et al. HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043). Bmc Infectious Diseases. 11: 251. PMID 21943026 DOI: 10.1186/1471-2334-11-251 |
0.647 |
|
| 2011 |
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, ... ... Eshleman SH, et al. Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine. 365: 493-505. PMID 21767103 DOI: 10.1056/Nejmoa1105243 |
0.638 |
|
| 2011 |
Taha TE, James MM, Hoover DR, Sun J, Laeyendecker O, Mullis CE, Kumwenda JJ, Lingappa JR, Auvert B, Morrison CS, Mofensen LM, Taylor A, Fowler MG, Kumenda NI, Eshleman SH. Association of recent HIV infection and in-utero HIV-1 transmission. Aids (London, England). 25: 1357-64. PMID 21572305 DOI: 10.1097/Qad.0B013E3283489D45 |
0.851 |
|
| 2011 |
James MM, Wang L, Musoke P, Donnell D, Fogel J, Towler WI, Khaki L, Nakabiito C, Jackson JB, Eshleman SH. Association of HIV diversity and survival in HIV-infected Ugandan infants. Plos One. 6: e18642. PMID 21533179 DOI: 10.1371/Journal.Pone.0018642 |
0.888 |
|
| 2011 |
Fogel J, Hoover DR, Sun J, Mofenson LM, Fowler MG, Taylor AW, Kumwenda N, Taha TE, Eshleman SH. Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis. Aids (London, England). 25: 911-7. PMID 21487249 DOI: 10.1097/Qad.0B013E328344Fedc |
0.839 |
|
| 2011 |
Fogel J, Li Q, Taha TE, Hoover DR, Kumwenda NI, Mofenson LM, Kumwenda JJ, Fowler MG, Thigpen MC, Eshleman SH. Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 1069-76. PMID 21460326 DOI: 10.1093/Cid/Cir008 |
0.816 |
|
| 2010 |
Church JD, Huang W, Mwatha A, Musoke P, Jackson JB, Bagenda D, Omer SB, Donnell D, Nakabiito C, Eure C, Guay LA, Taylor A, Bakaki PM, Matovu F, McConnell M, ... ... Eshleman SH, et al. Analysis of HIV tropism in Ugandan infants. Current Hiv Research. 8: 498-503. PMID 21073438 DOI: 10.2174/157016210793499187 |
0.862 |
|
| 2010 |
Laeyendecker O, Church JD, Oliver AE, Mwatha A, Owen SM, Donnell D, Brookmeyer R, Musoke P, Jackson JB, Guay L, Nakabiito C, Quinn TC, Eshleman SH. Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. Plos One. 5: e13259. PMID 20949006 DOI: 10.1371/Journal.Pone.0013259 |
0.865 |
|
| 2010 |
Palumbo P, Lindsey JC, Hughes MD, Cotton MF, Bobat R, Meyers T, Bwakura-Dangarembizi M, Chi BH, Musoke P, Kamthunzi P, Schimana W, Purdue L, Eshleman SH, Abrams EJ, Millar L, et al. Antiretroviral treatment for children with peripartum nevirapine exposure. The New England Journal of Medicine. 363: 1510-20. PMID 20942667 DOI: 10.1056/Nejmoa1000931 |
0.473 |
|
| 2010 |
Lockman S, Hughes MD, McIntyre J, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash A, Hosseinipour MC, Mohapi L, Stringer E, Mngqibisa R, Siika A, Atwine D, Hakim J, ... ... Eshleman S, et al. Antiretroviral therapies in women after single-dose nevirapine exposure. The New England Journal of Medicine. 363: 1499-509. PMID 20942666 DOI: 10.1056/Nejmoa0906626 |
0.544 |
|
| 2010 |
Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson JB, Eshleman SH. Analysis of HIV diversity using a high-resolution melting assay. Aids Research and Human Retroviruses. 26: 913-8. PMID 20666583 DOI: 10.1089/Aid.2009.0259 |
0.806 |
|
| 2010 |
Kim HN, Wang J, Hughes J, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH, Khaki L, McMahon MA, Siliciano RF, Wald A, Celum C. Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection. The Journal of Infectious Diseases. 202: 734-8. PMID 20649426 DOI: 10.1086/655662 |
0.715 |
|
| 2010 |
Towler WI, Barlow-Mosha L, Church JD, Bagenda D, Ajuna P, Mubiru M, Musoke P, Eshleman SH. Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. Aids Research and Human Retroviruses. 26: 563-8. PMID 20455758 DOI: 10.1089/Aid.2009.0164 |
0.797 |
|
| 2010 |
Flexner C, Tierney C, Gross R, Andrade A, Lalama C, Eshleman SH, Aberg J, Sanne I, Parsons T, Kashuba A, Rosenkranz SL, Kmack A, Ferguson E, Dehlinger M, Mildvan D, et al. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 1041-52. PMID 20192725 DOI: 10.1086/651118 |
0.496 |
|
| 2010 |
Gupta A, Saple DG, Nadkarni G, Shah B, Vaidya S, Hingankar N, Chaturbhuj D, Deshmukh P, Walshe L, Hudelson SE, James M, Paranjape RS, Eshleman SH, Tripathy S. One-, two-, and three-class resistance among HIV-infected patients on antiretroviral therapy in private care clinics: Mumbai, India. Aids Research and Human Retroviruses. 26: 25-31. PMID 20063995 DOI: 10.1089/Aid.2009.0102 |
0.806 |
|
| 2010 |
Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, Bakaki PM, Thigpen MC, Mubiru M, Fowler MG, Eshleman SH. Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. Aids (London, England). 24: 557-61. PMID 20057308 DOI: 10.1097/Qad.0B013E3283346E60 |
0.445 |
|
| 2010 |
Lidström J, Li Q, Hoover DR, Kafulafula G, Mofenson LM, Fowler MG, Thigpen MC, Kumwenda N, Taha TE, Eshleman SH. Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero. Aids (London, England). 24: 381-6. PMID 19996936 DOI: 10.1097/Qad.0B013E3283352Ef1 |
0.613 |
|
| 2009 |
Huang W, Toma J, Stawiski E, Fransen S, Wrin T, Parkin N, Whitcomb JM, Coakley E, Hecht FM, Deeks SG, Gandhi RT, Eshleman SH, Petropoulos CJ. Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals. Aids Research and Human Retroviruses. 25: 795-802. PMID 19678765 DOI: 10.1089/Aid.2008.0252 |
0.33 |
|
| 2009 |
Church JD, Huang W, Parkin N, Marlowe N, Guay LA, Omer SB, Musoke P, Jackson JB, Eshleman SH. Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. Aids Research and Human Retroviruses. 25: 657-63. PMID 19621988 DOI: 10.1089/Aid.2008.0235 |
0.888 |
|
| 2009 |
Mmiro FA, Aizire J, Mwatha AK, Eshleman SH, Donnell D, Fowler MG, Nakabiito C, Musoke PM, Jackson JB, Guay LA. Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 32-9. PMID 19617849 DOI: 10.1097/Qai.0B013E3181Afd352 |
0.684 |
|
| 2009 |
Gross R, Tierney C, Andrade A, Lalama C, Rosenkranz S, Eshleman SH, Flanigan T, Santana J, Salomon N, Reisler R, Wiggins I, Hogg E, Flexner C, Mildvan D. Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial. Archives of Internal Medicine. 169: 1224-32. PMID 19597072 DOI: 10.1001/Archinternmed.2009.172 |
0.447 |
|
| 2009 |
Huang W, Eshleman SH, Toma J, Stawiski E, Whitcomb JM, Jackson JB, Guay L, Musoke P, Parkin N, Petropoulos CJ. Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs. Aids (London, England). 23: 1903-8. PMID 19593079 DOI: 10.1097/Qad.0B013E32832F1802 |
0.56 |
|
| 2009 |
Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, ... Eshleman SH, et al. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. Aids Research and Human Retroviruses. 25: 673-7. PMID 19552593 DOI: 10.1089/Aid.2009.0003 |
0.835 |
|
| 2009 |
Hudelson SE, Marlowe N, Huang W, Bruce R, Church JD, Husnik M, Donnell D, Coates T, Jackson JB, Chesney M, Koblin B, Eshleman SH. Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors. Aids Research and Human Retroviruses. 25: 701-5. PMID 19552592 DOI: 10.1089/Aid.2009.0014 |
0.843 |
|
| 2009 |
Eshleman SH, Khaki L, Laeyendecker O, Piwowar-Manning E, Johnson-Lewis L, Husnik M, Koblin B, Coates T, Chesney M, Vallari A, Devare SG, Hackett J. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 121-4. PMID 19506484 DOI: 10.1097/Qai.0B013E3181Ab61E1 |
0.703 |
|
| 2009 |
Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, et al. Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1. The Journal of Infectious Diseases. 199: 1301-9. PMID 19338474 DOI: 10.1086/597759 |
0.603 |
|
| 2009 |
Eshleman SH, Hudelson SE, Smith P, Hackett J, Holzmayer V, Swanson P, Devare SG, Marlowe N. Analysis of pol integrase sequences in diverse HIV type 1 strains using a prototype genotyping assay. Aids Research and Human Retroviruses. 25: 343-5. PMID 19327053 DOI: 10.1089/Aid.2008.0236 |
0.621 |
|
| 2009 |
Eshleman SH, Laeyendecker O, Parkin N, Huang W, Chappey C, Paquet AC, Serwadda D, Reynolds SJ, Kiwanuka N, Quinn TC, Gray R, Wawer M. Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda. Aids (London, England). 23: 845-52. PMID 19276794 DOI: 10.1097/Qad.0B013E328327957A |
0.645 |
|
| 2009 |
Church JD, Eshleman SH. Reply to Krivine et al. Journal of Infectious Diseases. 199: 1554-1555. DOI: 10.1086/598480 |
0.675 |
|
| 2008 |
Towler WI, Church JD, Eshleman JR, Fowler MG, Guay LA, Jackson JB, Eshleman SH. Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq). Aids Research and Human Retroviruses. 24: 1209-13. PMID 18788912 DOI: 10.1089/Aid.2008.0109 |
0.846 |
|
| 2008 |
Church JD, Omer SB, Guay LA, Huang W, Lidstrom J, Musoke P, Mmiro F, Jackson JB, Eshleman SH. Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. The Journal of Infectious Diseases. 198: 1075-82. PMID 18684096 DOI: 10.1086/591503 |
0.864 |
|
| 2008 |
Flys TS, McConnell MS, Matovu F, Church JD, Bagenda D, Khaki L, Bakaki P, Thigpen MC, Eure C, Fowler MG, Eshleman SH. Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission. The Journal of Infectious Diseases. 198: 465-9. PMID 18582198 DOI: 10.1086/590160 |
0.865 |
|
| 2008 |
Collier AC, Tierney C, Downey GF, Eshleman SH, Kashuba A, Klingman K, Vergis EN, Pakes GE, Rooney JF, Rinehart A, Mellors JW. Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. Hiv Clinical Trials. 9: 91-102. PMID 18474494 DOI: 10.1310/Hct0902-91 |
0.401 |
|
| 2008 |
Church JD, Huang W, Mwatha A, Toma J, Stawiski E, Donnell D, Guay LA, Mmiro F, Musoke P, Jackson JB, Parkin N, Eshleman SH. HIV-1 tropism and survival in vertically infected Ugandan infants. The Journal of Infectious Diseases. 197: 1382-8. PMID 18444795 DOI: 10.1086/587492 |
0.861 |
|
| 2008 |
Church JD, Towler WI, Hoover DR, Hudelson SE, Kumwenda N, Taha TE, Eshleman JR, Eshleman SH. Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants. Aids Research and Human Retroviruses. 24: 595-605. PMID 18370589 DOI: 10.1089/Aid.2007.0224 |
0.826 |
|
| 2008 |
Demeter LM, DeGruttola V, Lustgarten S, Bettendorf D, Fischl M, Eshleman S, Spreen W, Nguyen BY, Koval CE, Eron JJ, Hammer S, Squires K. Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience. Hiv Clinical Trials. 9: 11-25. PMID 18215978 DOI: 10.1310/Hct0901-11 |
0.584 |
|
| 2007 |
Eshleman SH, Hudelson SE, Bruce R, Lee T, Owens MR, Hackett J, Swanson P, Devare SG, Marlowe N. Analysis of HIV type 1 gp41 sequences in diverse HIV type 1 strains. Aids Research and Human Retroviruses. 23: 1593-8. PMID 18160019 DOI: 10.1089/Aid.2007.0130 |
0.644 |
|
| 2007 |
Flys TS, Mwatha A, Guay LA, Nakabiito C, Donnell D, Musoke P, Mmiro F, Jackson JB, Eshleman SH. Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine. Aids (London, England). 21: 2077-82. PMID 17885298 DOI: 10.1097/Qad.0B013E3282703847 |
0.877 |
|
| 2007 |
McConnell MS, Stringer JS, Kourtis AP, Weidle PJ, Eshleman SH. Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter? American Journal of Obstetrics and Gynecology. 197: S56-63. PMID 17825651 DOI: 10.1016/J.Ajog.2007.02.031 |
0.456 |
|
| 2007 |
Church JD, Hudelson SE, Guay LA, Chen S, Hoover DR, Parkin N, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Eshleman SH. HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. Aids Research and Human Retroviruses. 23: 764-8. PMID 17604538 DOI: 10.1089/Aid.2006.0272 |
0.829 |
|
| 2007 |
Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnell D, Mmiro F, Musoke P, Guay LA, Jackson JB, Parkin NT, Petropoulos CJ. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. Journal of Virology. 81: 7885-93. PMID 17507467 DOI: 10.1128/Jvi.00218-07 |
0.567 |
|
| 2007 |
Eshleman SH, Husnik M, Hudelson S, Donnell D, Huang Y, Huang W, Hart S, Jackson B, Coates T, Chesney M, Koblin B. Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection. Aids (London, England). 21: 1165-74. PMID 17502727 DOI: 10.1097/Qad.0B013E32810Fd72E |
0.735 |
|
| 2007 |
Flys TS, Donnell D, Mwatha A, Nakabiito C, Musoke P, Mmiro F, Jackson JB, Guay LA, Eshleman SH. Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. The Journal of Infectious Diseases. 195: 711-5. PMID 17262714 DOI: 10.1086/511433 |
0.882 |
|
| 2006 |
Church JD, Jones D, Flys T, Hoover D, Marlowe N, Chen S, Shi C, Eshleman JR, Guay LA, Jackson JB, Kumwenda N, Taha TE, Eshleman SH. Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. The Journal of Molecular Diagnostics : Jmd. 8: 430-2; quiz 527. PMID 16931582 DOI: 10.2353/Jmoldx.2006.050148 |
0.859 |
|
| 2006 |
Eshleman SH, Church JD, Chen S, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Hoover DR. Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 518-21. PMID 16810119 DOI: 10.1097/01.Qai.0000221676.22069.B8 |
0.839 |
|
| 2006 |
Flys TS, Chen S, Jones DC, Hoover DR, Church JD, Fiscus SA, Mwatha A, Guay LA, Mmiro F, Musoke P, Kumwenda N, Taha TE, Jackson JB, Eshleman SH. Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 610-3. PMID 16773030 DOI: 10.1097/01.Qai.0000221686.67810.20 |
0.877 |
|
| 2006 |
Eshleman SH, Lie Y, Hoover DR, Chen S, Hudelson SE, Fiscus SA, Petropoulos CJ, Kumwenda N, Parkin N, Taha TE. Association between the replication capacity and mother-to-child transmission of HIV-1, in antiretroviral drug-naive Malawian women. The Journal of Infectious Diseases. 193: 1512-5. PMID 16652278 DOI: 10.1086/503810 |
0.675 |
|
| 2006 |
Eshleman SH, Jones D, Galovich J, Paxinos EE, Petropoulos CJ, Jackson JB, Parkin N. Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations. Aids Research and Human Retroviruses. 22: 289-93. PMID 16545016 DOI: 10.1089/Aid.2006.22.289 |
0.648 |
|
| 2006 |
Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Mâsse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L. Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. Aids (London, England). 20: 543-51. PMID 16470118 DOI: 10.1097/01.Aids.0000210608.70762.C3 |
0.629 |
|
| 2006 |
Eshleman SH, Hoover DR, Hudelson SE, Chen S, Fiscus SA, Piwowar-Manning E, Jackson JB, Kumwenda NI, Taha TE. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1 Journal of Infectious Diseases. 193: 479-481. PMID 16425125 DOI: 10.1016/J.Jinf.2006.03.013 |
0.527 |
|
| 2005 |
Eshleman SH, Hoover DR, Chen S, Hudelson SE, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Jackson JB, Kumwenda N, Taha T. Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns. Aids (London, England). 19: 2167-9. PMID 16284468 DOI: 10.1097/01.Aids.0000194800.43799.94 |
0.521 |
|
| 2005 |
Flys T, Marlowe N, Hackett J, Parkin N, Schumaker M, Holzmayer V, Hay P, Eshleman SH. Analysis of PTAP duplications in the gag p6 region of subtype C HIV type 1. Aids Research and Human Retroviruses. 21: 739-41. PMID 16131315 DOI: 10.1089/Aid.2005.21.739 |
0.86 |
|
| 2005 |
Eshleman SH, Guay LA, Wang J, Mwatha A, Brown ER, Musoke P, Mmiro F, Jackson JB. Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 24-9. PMID 16123677 DOI: 10.1097/01.Qai.0000174656.71276.D6 |
0.477 |
|
| 2005 |
Huang DD, Bremer JW, Brambilla DJ, Palumbo PE, Aldrovandi G, Eshleman S, Brown C, Fiscus S, Frenkel L, Hamdan H, Hart S, Kovacs A, Krogstad P, LaRussa P, Sullivan J, et al. Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assays. Journal of Clinical Microbiology. 43: 3963-70. PMID 16081937 DOI: 10.1128/JCM.43.8.3963-3970.2005 |
0.41 |
|
| 2005 |
Eshleman SH, Guay LA, Mwatha A, Brown E, Musoke P, Mmiro F, Jackson JB. Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 593-7. PMID 16044013 |
0.579 |
|
| 2005 |
Jones D, Parkin N, Hudelson SE, Guay LA, Musoke P, Mmiro F, Jackson JB, Eshleman SH. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine. Aids Research and Human Retroviruses. 21: 319-24. PMID 15943576 DOI: 10.1089/Aid.2005.21.319 |
0.516 |
|
| 2005 |
Eshleman SH, Hoover DR, Chen S, Hudelson SE, Guay LA, Mwatha A, Fiscus SA, Mmiro F, Musoke P, Jackson JB, Kumwenda N, Taha T. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. The Journal of Infectious Diseases. 192: 30-6. PMID 15942891 DOI: 10.1086/430764 |
0.625 |
|
| 2005 |
Flys T, Nissley DV, Claasen CW, Jones D, Shi C, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH. Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. The Journal of Infectious Diseases. 192: 24-9. PMID 15942890 DOI: 10.1086/430742 |
0.882 |
|
| 2005 |
Eshleman SH, Crutcher G, Petrauskene O, Kunstman K, Cunningham SP, Trevino C, Davis C, Kennedy J, Fairman J, Foley B, Kop J. Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer. Journal of Clinical Microbiology. 43: 813-7. PMID 15695685 DOI: 10.1128/Jcm.43.2.813-817.2005 |
0.512 |
|
| 2005 |
Eshleman SH, Hudelson SE, Gupta A, Bollinger R, Divekar AD, Gangakhedkar RR, Kulkarni SS, Thakar MR, Paranjape RS, Tripathy S. Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India. Aids Research and Human Retroviruses. 21: 93-7. PMID 15665648 DOI: 10.1089/Aid.2005.21.93 |
0.707 |
|
| 2004 |
Shi C, Eshleman SH, Jones D, Fukushima N, Hua L, Parker AR, Yeo CJ, Hruban RH, Goggins MG, Eshleman JR. LigAmp for sensitive detection of single-nucleotide differences. Nature Methods. 1: 141-7. PMID 15782177 DOI: 10.1038/Nmeth713 |
0.421 |
|
| 2004 |
Marlowe N, Flys T, Hackett J, Schumaker M, Jackson JB, Eshleman SH. Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains. Aids Research and Human Retroviruses. 20: 1119-25. PMID 15585104 DOI: 10.1089/Aid.2004.20.1119 |
0.851 |
|
| 2004 |
Demeter LM, Ribaudo HJ, Erice A, Eshleman SH, Hammer SM, Hellmann NS, Fischl MA. HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 552-8. PMID 15356820 DOI: 10.1086/422518 |
0.633 |
|
| 2004 |
Eshleman SH, Guay LA, Mwatha A, Cunningham SP, Brown ER, Musoke P, Mmiro F, Jackson JB. Comparison of nevirapine (NVP) resistance in ugandan women 7 days vs. 6-8 weeks after single-dose NVP prophylaxis: HIVNET 012 Aids Research and Human Retroviruses. 20: 595-599. PMID 15242535 DOI: 10.1089/0889222041217518 |
0.418 |
|
| 2004 |
Eshleman SH, Hackett J, Swanson P, Cunningham SP, Drews B, Brennan C, Devare SG, Zekeng L, Kaptué L, Marlowe N. Performance of the Celera Diagnostics ViroSeq HIV-1 genotyping system for sequence-based analysis of diverse human immunodeficiency virus type 1 strains Journal of Clinical Microbiology. 42: 2711-2717. PMID 15184457 DOI: 10.1128/Jcm.42.6.2711-2717.2004 |
0.566 |
|
| 2004 |
Eshleman SH, Guay LA, Mwatha A, Brown ER, Cunningham SP, Musoke P, Mmiro F, Jackson JB. Characterization of Nevirapine Resistance Mutations in Women with Subtype A Vs. D HIV-1 6-8 Weeks after Single-Dose Nevirapine (HIVNET 012) Journal of Acquired Immune Deficiency Syndromes. 35: 126-130. PMID 14722443 DOI: 10.1097/00126334-200402010-00004 |
0.62 |
|
| 2003 |
Shetty AK, Coovadia HM, Mirochnick MM, Maldonado Y, Mofenson LM, Eshleman SH, Fleming T, Emel L, George K, Katzenstein DA, Wells J, Maponga CC, Mwatha A, Jones SA, Abdool Karim SS, et al. Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months. Journal of Acquired Immune Deficiency Syndromes (1999). 34: 482-90. PMID 14657758 DOI: 10.1097/00126334-200312150-00006 |
0.395 |
|
| 2003 |
Eshleman SH, Jones D, Flys T, Petrauskene O, Jackson JB. Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq™ HIV-1 Genotyping System Biotechniques. 35: 614-622. PMID 14513567 DOI: 10.2144/03353Dd05 |
0.9 |
|
| 2003 |
Huang DD, Eshleman SH, Brambilla DJ, Palumbo PE, Bremer JW. Evaluation of the editing process in human immunodeficiency virus type 1 genotyping Journal of Clinical Microbiology. 41: 3265-3272. PMID 12843074 DOI: 10.1128/Jcm.41.7.3265-3272.2003 |
0.473 |
|
| 2002 |
Eshleman SH, Guay LA, Fleming T, Mwatha A, Mracna M, Becker-Pergola G, Musoke P, Mmiro F, Jackson JB. Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012) Journal of Acquired Immune Deficiency Syndromes. 31: 327-330. PMID 12439209 DOI: 10.1097/00126334-200211010-00009 |
0.716 |
|
| 2002 |
Klevytska AM, Mracna MR, Guay L, Becker-Pergola G, Furtado M, Zhang L, Jackson JB, Eshleman SH. Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from Uganda. Aids Research and Human Retroviruses. 18: 791-6. PMID 12167271 DOI: 10.1089/08892220260139530 |
0.445 |
|
| 2002 |
Eshleman SH, Jackson JB. Nevirapine resistance after single dose prophylaxis Aids Reviews. 4: 59-63. PMID 12152519 |
0.641 |
|
| 2002 |
Eshleman SH, Gonzales MJ, Becker-Pergola G, Cunningham SC, Guay LA, Jackson JB, Shafer RW. Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D. Aids Research and Human Retroviruses. 18: 507-11. PMID 12015904 DOI: 10.1089/088922202317406655 |
0.534 |
|
| 2002 |
Krogstad P, Nachman S, Palumbo P, Eshleman SH, Geng Y, Jackson JB, Wantman M, Korber B, Lang D, Wiznia A, Johnson G. Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1 Aids Research and Human Retroviruses. 18: 413-417. PMID 11958684 DOI: 10.1089/088922202753614173 |
0.563 |
|
| 2001 |
Mracna M, Becker-Pergola G, Dileanis J, Guay LA, Cunningham S, Jackson JB, Eshleman SH. Performance of applied biosystems ViroSeq HIV-1 genotyping system for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda Journal of Clinical Microbiology. 39: 4323-4327. PMID 11724839 DOI: 10.1128/Jcm.39.12.4323-4327.2001 |
0.659 |
|
| 2001 |
Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Fowler MG, Mofenson LM, Mmiro F, Jackson JB. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) Aids. 15: 1951-1957. PMID 11600822 DOI: 10.1097/00002030-200110190-00006 |
0.686 |
|
| 2001 |
Eshleman SH, Becker-Pergola G, Deseyve M, Guay LA, Mracna M, Fleming T, Cunningham S, Musoke P, Mmiro F, Jackson JB. Impact of human immunodeficiency virus type 1 (HIV-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIV Network for Prevention Trials 012 study) Journal of Infectious Diseases. 184: 914-917. PMID 11509999 DOI: 10.1086/323153 |
0.71 |
|
| 2001 |
Eshleman SH, Krogstad P, Brooks Jackson J, Wang YG, Lee S, Wei LJ, Cunningham S, Wantman M, Wiznia A, Johnson G, Nachman S, Palumbo P. Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377) Journal of Infectious Diseases. 183: 1732-1738. PMID 11372025 DOI: 10.1086/320728 |
0.356 |
|
| 2001 |
Cunningham S, Ank B, Lewis D, Lu W, Wantman M, Dileanis J, Jackson JB, Palumbo P, Krogstad P, Eshleman SH. Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) Genotyping System for sequence-based analysis of HIV-1 in pediatric plasma samples Journal of Clinical Microbiology. 39: 1254-1257. PMID 11283037 DOI: 10.1128/JCM.39.4.1254-1257.2001 |
0.572 |
|
| 2000 |
Raines CP, Flexner C, Sun E, Heath-Chiozzi M, Lewis RH, Fields C, Deetz C, Apuzzo L, Eshleman SH, Jackson JB, Gallant JE. Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks. Journal of Acquired Immune Deficiency Syndromes (1999). 25: 322-8. PMID 11114832 DOI: 10.1097/00042560-200012010-00005 |
0.502 |
|
| 2000 |
Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, Mofenson LM, Mirochnick M, Mmiro F, Eshleman SH. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission Aids. 14: F111-F115. PMID 10983633 DOI: 10.1097/00002030-200007280-00001 |
0.648 |
|
| 2000 |
Becker-Pergola G, Mellquist JL, Guay L, Mmiro F, Ndugwa C, Kataaha P, Jackson JB, Eshleman SH. Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women Aids Research and Human Retroviruses. 16: 1099-1104. PMID 10954884 DOI: 10.1089/088922200414938 |
0.712 |
|
| 2000 |
Becker-Pergola G, Kataaha P, Johnston-Dow L, Fung S, Jackson JB, Eshleman SH. Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults Aids Research and Human Retroviruses. 16: 807-813. PMID 10826487 DOI: 10.1089/088922200308800 |
0.626 |
|
| 1999 |
Becker-Pergola G, Mellquist JL, Eshleman JR, Brooks Jackson J, Eshleman SH. Improved detection of human immunodeficiency virus type 1 variants by analysis of replicate amplification reactions: Relevance to studies of human immunodeficiency virus type 1 vertical transmission Molecular Diagnosis. 4: 261-268. PMID 10671637 DOI: 10.1016/S1084-8592(99)80001-0 |
0.582 |
|
| 1999 |
Mellquist JL, Becker-Pergola G, Gu J, Guay L, Himes L, Kataaha P, Mmiro F, Ndugwa C, Jackson JB, Eshleman SH. Dual transmission of subtype A and D HIV type 1 viruses from a Ugandan woman to her infant Aids Research and Human Retroviruses. 15: 217-221. PMID 10029253 DOI: 10.1089/088922299311637 |
0.621 |
|
| 1998 |
Mellquist JL, Bowman B, Kasturi L, Guay L, Kataaha P, Mmiro F, Ndugwa C, Jackson JB, Eshleman SH. Characterization of HIV type 1 gp120 V3 region sequences from Ugandan infants Aids Research and Human Retroviruses. 14: 1391-1395. PMID 9788681 DOI: 10.1089/Aid.1998.14.1391 |
0.562 |
|
| Show low-probability matches. |
